CN1097322A - Oral liquid for decreasing blood sugar and compound method thereof - Google Patents
Oral liquid for decreasing blood sugar and compound method thereof Download PDFInfo
- Publication number
- CN1097322A CN1097322A CN 93112071 CN93112071A CN1097322A CN 1097322 A CN1097322 A CN 1097322A CN 93112071 CN93112071 CN 93112071 CN 93112071 A CN93112071 A CN 93112071A CN 1097322 A CN1097322 A CN 1097322A
- Authority
- CN
- China
- Prior art keywords
- grams
- fructus
- compound method
- blood sugar
- adds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to a kind of health care and treatment medicine---oral liquid for decreasing blood sugar and compound method thereof for the treatment of diabetes, be characterised in that its prescription is: get Radix Ophiopogonis, Rhizoma Polygonati Odorati, Rhizoma Dioscoreae, Radix Pseudostellariae, the Radix Astragali, Fructus Schisandrae Chinensis, Fructus Lycii, Gypsum Fibrosum, Fructus Mume, Fructus Crataegi, Stigma Maydis; Its compound method is: get above-mentioned all medicines in proportion and smash, water logging merges after twice decoction, concentrates, and adds kieselguhr and stirs sedimentation, centrifugal making.The present invention has curative effect preferably to the symptom treatment of diabetics, and total effective rate reaches more than 80%, and blood glucose, glucose in urine are had significant property difference P<0.01.
Description
The invention belongs to the health care and treatment medicine-oral liquid for decreasing blood sugar and compound method thereof of a kind of treatment diabetes (diabetes).
At present, diabetes are adopted Western medicine, treatment by Chinese herbs more, the injection of insulin injection is wherein arranged; Oral sulfonylurea drugs; Oral biguanides etc.Taking Western medicine for a long time can have side effects.
The objective of the invention is provides the high health care of a kind of curative effect and treatment medicine-oral liquid for decreasing blood sugar and compound method thereof for diabetics.
Oral liquid for decreasing blood sugar of the present invention and compound method content Description thereof:
Oral liquid for decreasing blood sugar of the present invention and compound method thereof are characterised in that its formula proportion is: get gram Radix Ophiopogonis 10~20, Rhizoma Polygonati Odorati 10~20 grams, Rhizoma Dioscoreae 25~35 grams, Radix Pseudostellariae 10~20 grams, the Radix Astragali 10~20 grams, Fructus Schisandrae Chinensis 3~10 grams, Fructus Lycii 5~15 grams, Gypsum Fibrosum 5~15 grams, Fructus Mume 3~10 grams, Fructus Crataegi 5~10 grams, Stigma Maydis 20~30 grams; Its compound method is: Radix Ophiopogonis, Fructus Schisandrae Chinensis, Fructus Crataegi are smashed; Gypsum Fibrosum is smashed the water that adds 10 times of amounts and was decocted first 1 hour, adds all medicines again and soaks 1 hour, adds the water of 8 times of amounts, decocts taking liquid 1.5 hours; Decoct the decocting that adds 7 times of amounts second time and boil twice gained medicinal liquid of 1 hour taking liquid He And, be concentrated into 1300ml, add kieselguhr and stir, low temperature sedimentation 24 hours, exceed the speed limit 6000 rev/mins centrifugal, the clear liquor coarse filtration, adjust volume to 1000ml, PH=7-7.5, relative density 1.05-1.10, the fine straining embedding, sterilization is promptly.
Oral liquid for decreasing blood sugar of the present invention has curative effect preferably to the symptom treatment of diabetics, especially diseases such as the spiritlessness and weakness that improves the patient, dry mouth and throat, dysphoria with feverish sensation in the chest palms and soles, excessive thirst polydipsia, waist knee joint ache, polyuria there is significant curative effect, total effective rate reaches more than 80%, and the back patient's that takes medicine blood glucose, glucose in urine have significant difference (P<0.01).
Embodiment (one)
Getting gram Radix Ophiopogonis 10, Rhizoma Polygonati Odorati 10 grams, Fructus Crataegi 5 grams smashes; Gypsum Fibrosum 5 gram is smashed, and the water that adds 10 times of amounts was decocted first 1 hour, adds Rhizoma Dioscoreae 25 grams, Radix Pseudostellariae 10 grams, the Radix Astragali 10 grams, Fructus Schisandrae Chinensis 3 grams, Fructus Lycii 5 grams, Fructus Mume 3 grams, Stigma Maydis 20 grams again and soaks 1 hour, and the decocting that adds 8 times of amounts boils 1.5 hours taking liquids; The decocting that second time decoction adds 7 times of amounts boils twice gained medicinal liquid of 1 hour taking liquid He And and is concentrated into 1300ml, adding kieselguhr stirs, low temperature sedimentation 24 hours, exceed the speed limit 6000 rev/mins centrifugal, the clear liquor coarse filtration, adjust volume to 1000ml, PH=7-7.5, relative density 1.25-1.10, fine straining embedding, sterilization.
By observation that diabetics is taken medicine, blood glucose relatively has significant difference P<0.05 before and after the treatment.
Embodiment (two)
Get gram Radix Ophiopogonis 15, Rhizoma Polygonati Odorati 15 grams, Rhizoma Dioscoreae 30 grams, Radix Pseudostellariae 15 grams, the Radix Astragali 15 grams, Fructus Schisandrae Chinensis 3 grams, Fructus Lycii 10 grams, Gypsum Fibrosum 10 grams, Fructus Mume 5 grams, Fructus Crataegi 10 grams, Stigma Maydis 25 grams, adopt embodiment () compound method to make medicinal liquid.By to diabetes patient's clinical treatment observation, blood glucose relatively has utmost point significant difference P<0.01.
Embodiment (three)
Get gram Radix Ophiopogonis 20, Rhizoma Polygonati Odorati 20 grams, Rhizoma Dioscoreae 35 grams, Radix Pseudostellariae 20 grams, the Radix Astragali 20 grams, Fructus Schisandrae Chinensis 10 grams, Fructus Lycii 10 grams, Gypsum Fibrosum 15 grams, Fructus Mume 10 grams, Fructus Crataegi 10 grams, Stigma Maydis 30 grams.Make medicinal liquid with embodiment () compound method, by to the diabetics clinical treatment observation, blood glucose relatively has utmost point significant difference P<0.01.
Claims (1)
1, a kind of diabetic health care and treatment medicine-oral liquid for decreasing blood sugar and compound method thereof is characterized in that the formula proportion of oral liquid for decreasing blood sugar is: get gram Radix Ophiopogonis 10~20, Rhizoma Polygonati Odorati 10~20 grams, Rhizoma Dioscoreae 25~35 grams, Radix Pseudostellariae 10~20 grams, the Radix Astragali 10~20 grams, Fructus Schisandrae Chinensis 3~10 grams, Fructus Lycii 5~15 grams, Gypsum Fibrosum 5~15 gram Fructus Mumes 3~10 grams, Fructus Crataegi 5~10 grams, Stigma Maydis 20~30 grams; The compound method of oral liquid for decreasing blood sugar is: Radix Ophiopogonis, Fructus Schisandrae Chinensis, Fructus Crataegi are smashed; Gypsum Fibrosum is smashed, and the water that adds 10 times of amounts was decocted first 1 hour, adds all medicines again and soaks 1 hour, and the decocting that adds 8 times of amounts boils 1.5 hours taking liquids; Decocting the decocting that adds 7 times of amounts second time boiled 1 hour, twice gained medicinal liquid of taking liquid He And is concentrated into 1300ml, add kieselguhr and stir, low temperature sedimentation 24 hours, exceed the speed limit 6000 rev/mins centrifugal, the clear liquor coarse filtration, adjust volume to 1000ml, PH=7-7.5, relative density 1.25-1.10, fine straining embedding, sterilization.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 93112071 CN1097322A (en) | 1993-07-16 | 1993-07-16 | Oral liquid for decreasing blood sugar and compound method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 93112071 CN1097322A (en) | 1993-07-16 | 1993-07-16 | Oral liquid for decreasing blood sugar and compound method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1097322A true CN1097322A (en) | 1995-01-18 |
Family
ID=4989813
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 93112071 Pending CN1097322A (en) | 1993-07-16 | 1993-07-16 | Oral liquid for decreasing blood sugar and compound method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1097322A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1116052C (en) * | 2000-07-13 | 2003-07-30 | 郭连川 | 'Yidaosheng' capsules |
CN100337639C (en) * | 2005-07-01 | 2007-09-19 | 刘济坚 | Concentrated life-cultivating blood-sugar reducing beverge |
CN101757499B (en) * | 2010-01-21 | 2011-11-30 | 浙江中医药大学 | Traditional Chinese medicine composite for treating impaired glucose tolerance |
CN103976451A (en) * | 2014-04-25 | 2014-08-13 | 贵州三泓药业股份有限公司 | Radix pseudostellariae nutrition instant granules |
CN104800558A (en) * | 2015-04-27 | 2015-07-29 | 唐玉厚 | Medicine for treating diabetes |
-
1993
- 1993-07-16 CN CN 93112071 patent/CN1097322A/en active Pending
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1116052C (en) * | 2000-07-13 | 2003-07-30 | 郭连川 | 'Yidaosheng' capsules |
CN100337639C (en) * | 2005-07-01 | 2007-09-19 | 刘济坚 | Concentrated life-cultivating blood-sugar reducing beverge |
CN101757499B (en) * | 2010-01-21 | 2011-11-30 | 浙江中医药大学 | Traditional Chinese medicine composite for treating impaired glucose tolerance |
CN103976451A (en) * | 2014-04-25 | 2014-08-13 | 贵州三泓药业股份有限公司 | Radix pseudostellariae nutrition instant granules |
CN104800558A (en) * | 2015-04-27 | 2015-07-29 | 唐玉厚 | Medicine for treating diabetes |
CN104800558B (en) * | 2015-04-27 | 2018-06-12 | 唐玉厚 | A kind of drug for treating diabetes |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102028900B (en) | Traditional Chinese medicine for treating metabolic syndrome and preparation method thereof | |
CN1219543C (en) | Chinese medicine for invigorating liver, kidney and spleen, nourishing blood, tranquilizing mind relaxing bowels and the prepn process of the Chinese medicine prepn | |
CN1895547B (en) | Medicine for treating diabetes and its preparation | |
CN1097137A (en) | The puerpera uses lactation-promoting health-care oral liquor | |
CN101513492A (en) | Chinese medicament for treating diabetes | |
CN1097322A (en) | Oral liquid for decreasing blood sugar and compound method thereof | |
CN1069203C (en) | Drug for curing diabetes | |
CN100998782B (en) | Traditional Chinese medicine oral liquid for treating gastrointestinal disease and its preparing method | |
CN102423435A (en) | Chinese medicine for treating infantile malnutrition and preparation method thereof | |
CN1239668A (en) | Oral liquid for treating cardiac and cerebral vascular diseases and promoting blood circulation and its preparation process | |
CN101129614A (en) | Spleen-invigorating and qi-tonifying beverage | |
CN101129666A (en) | Wild jujube beverage for soothing nerves | |
CN103251827A (en) | Traditional Chinese medicine composition for treating diabetes mellitus and preparation method thereof | |
CN1181833C (en) | Instant hypoglycemic medicine | |
CN1192789C (en) | 'Shenhuaxiaokecha' tea and preparing method thereof | |
CN101953959A (en) | Chinese medicament for treating diabetic gastroparalysis | |
CN101279007B (en) | Chinese medicine for curing aconuresis | |
CN101129601A (en) | Fructus forsythiae beverage for toothache | |
CN1280835A (en) | Chinese-medicinal capsule for treating hyperlipomia | |
KR20010000070A (en) | Agents for diabetes and the manufacturing method thereof | |
CN103263580A (en) | Traditional Chinese medicine composition for treating diabetes | |
CN1306830A (en) | Medicine for treating type II diabetes | |
CN101637565A (en) | Pure Chinese medicinal preparation for treating arrhythmia | |
CN101558806A (en) | Health tea for nourishing blood and promoting blood circulation for middle-aged and old people | |
CN1034672A (en) | The prescription of integrated pulse liquor and technological process |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C01 | Deemed withdrawal of patent application (patent law 1993) | ||
WD01 | Invention patent application deemed withdrawn after publication |